GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
Abstract Exendin-4 is a long acting glucagon-like peptide 1 (GLP-1) analogue that is an agonist for the GLP-1 receptor, a G-protein coupled receptor (GPCR). Exendin-4 is used to clinically improve glucose tolerance in diabetic patients due to its ability to enhance insulin secretion. In rodents, and...
Enregistré dans:
Auteurs principaux: | Joseph Fusco, Xiangwei Xiao, Krishna Prasadan, Qingfeng Sheng, Congde Chen, Yung-Ching Ming, George Gittes |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/adbf0b4c28d74aa08e9ef0b15bfa14d9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Activation of the GLP-1 receptor by chloropyrimidine derivatives
par: Shaikha S. AlNeyadi, et autres
Publié: (2021) -
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
par: Mette Simone Aae Madsen, et autres
Publié: (2019) -
High proliferation and delamination during skin epidermal stratification
par: Mareike Damen, et autres
Publié: (2021) -
Targeting GLP-1 receptor trafficking to improve agonist efficacy
par: Ben Jones, et autres
Publié: (2018) -
Role and development of GLP-1 receptor agonists in the management of diabetes
par: Chee W Chia, et autres
Publié: (2009)